BREAKING
Synergy CHC Corp. (SNYR) Misses Q4 EPS Estimates 2 hours ago Lamb Weston Holdings, Inc. (LW) Reports Q3 Earnings 2 hours ago Primoris Services Corporation (PRIM) Jumps 7.2% to $153.46 2 hours ago ACM Research, Inc. (ACMR) Jumps 6.5% to $41.90 3 hours ago PBF Energy Inc. (PBF) Drops 5.6% to $47.47 3 hours ago UniFirst Corporation (UNF) Reports Q2 Earnings 3 hours ago Rh (RH) Plunges 22.2% to $108.81 3 hours ago Semtech Corporation (SMTC) Jumps 6.1% to $81.58 3 hours ago Veeco Instruments Inc. (VECO) Jumps 5.9% to $35.87 3 hours ago Ciena Corporation (CIEN) Jumps 7.6% to $417.82 3 hours ago Synergy CHC Corp. (SNYR) Misses Q4 EPS Estimates 2 hours ago Lamb Weston Holdings, Inc. (LW) Reports Q3 Earnings 2 hours ago Primoris Services Corporation (PRIM) Jumps 7.2% to $153.46 2 hours ago ACM Research, Inc. (ACMR) Jumps 6.5% to $41.90 3 hours ago PBF Energy Inc. (PBF) Drops 5.6% to $47.47 3 hours ago UniFirst Corporation (UNF) Reports Q2 Earnings 3 hours ago Rh (RH) Plunges 22.2% to $108.81 3 hours ago Semtech Corporation (SMTC) Jumps 6.1% to $81.58 3 hours ago Veeco Instruments Inc. (VECO) Jumps 5.9% to $35.87 3 hours ago Ciena Corporation (CIEN) Jumps 7.6% to $417.82 3 hours ago
ADVERTISEMENT
MRK

Merck & Co., Inc.

$MRK NYSE Oct 28, 2021 BMO Q3 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

MRK Coverage

Event Merck & Co., Inc. (MRK) Q1 2026 Earnings Call Apr 1, 2026 Event Merck & Co., Inc. (MRK) Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins Mar 30, 2026 Event Merck & Co., Inc. (MRK) Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction Mar 29, 2026 Transcript Merck & Co., Inc. (MRK) Q4 2025 Earnings Call Transcript Feb 4, 2026 Transcript Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Merck & Co., Inc. (MRK) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Key highlights from Merck’s (MRK) Q3 2025 earnings results Oct 30, 2025 News Infographic: How Merck (MRK) performed in Q3 2024 Oct 31, 2024